Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Arcangelo Prete et al.|Bone Marrow Transplantation|2020Cited by 61
Long-Term Outcomes of Cord Blood Transplantation from an HLA-Identical Sibling for Patients with Bone Marrow Failure Syndromes: A Report From Eurocord, Cord Blood Committee and Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow TransplantationSimona Pagliuca, Annalisa Ruggeri, Régis Peffault de Latour et al.|Transplantation and Cellular Therapy|2017Cited by 28
Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP StudyAndré Willasch, Peter Bader, Christina Peters et al.|Blood|2017Cited by 2
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Christina Peters et al.|Bone Marrow Transplantation|2021Cited by 1